IONSPartnership•prnewswire•
Orsini Selected as Exclusive Specialty Pharmacy Partner for Ionis' DAWNZERA™ (donidalorsen)
Sentiment:Positive (70)
Summary
DAWNZERA is an FDA-approved prophylactic medicine for the treatment of hereditary angioedema (HAE), self-administered via subcutaneous auto-injector ELK GROVE VILLAGE, Ill., Aug. 25, 2025 /PRNewswire/ -- Orsini, a leader in rare disease pharmacy solutions, announced today that it is the...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by prnewswire